BR112013022209A2 - preparação farmacêutica sólida revestida - Google Patents

preparação farmacêutica sólida revestida

Info

Publication number
BR112013022209A2
BR112013022209A2 BR112013022209A BR112013022209A BR112013022209A2 BR 112013022209 A2 BR112013022209 A2 BR 112013022209A2 BR 112013022209 A BR112013022209 A BR 112013022209A BR 112013022209 A BR112013022209 A BR 112013022209A BR 112013022209 A2 BR112013022209 A2 BR 112013022209A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical preparation
solid pharmaceutical
coated solid
coated
solid
Prior art date
Application number
BR112013022209A
Other languages
English (en)
Inventor
Heike Bley
Lauri Lehtonen
Luc Van Der Heyden
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BR112013022209A2 publication Critical patent/BR112013022209A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

resumo patente de invenção: "preparação farmacêutica sólida revestida". a presente invenção refere-se a preparações farmacêuticas sólidas revestidas com uma camada muito fina na gama nanométrica e um método para produzir tais preparações. a preparação farmacêutica sólida revestida pode ser preparada usando camada de deposição atômica (ald).
BR112013022209A 2011-03-03 2012-03-01 preparação farmacêutica sólida revestida BR112013022209A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11001791 2011-03-03
PCT/EP2012/000883 WO2012116814A1 (en) 2011-03-03 2012-03-01 Coated solid pharmaceutical preparation

Publications (1)

Publication Number Publication Date
BR112013022209A2 true BR112013022209A2 (pt) 2016-12-06

Family

ID=45808746

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013022209A BR112013022209A2 (pt) 2011-03-03 2012-03-01 preparação farmacêutica sólida revestida

Country Status (13)

Country Link
US (1) US20130337056A1 (pt)
EP (1) EP2680824A1 (pt)
JP (1) JP2014510066A (pt)
KR (1) KR20140011358A (pt)
CN (1) CN103402503A (pt)
AU (1) AU2012222650A1 (pt)
BR (1) BR112013022209A2 (pt)
CA (1) CA2828754A1 (pt)
CL (1) CL2013002504A1 (pt)
EA (1) EA201300982A1 (pt)
MX (1) MX2013010002A (pt)
WO (1) WO2012116814A1 (pt)
ZA (1) ZA201307372B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI126168B (en) * 2012-09-18 2016-07-29 Novaldmedical Ltd Oy A method for coating pharmaceutical substrates
LT3003286T (lt) 2013-05-24 2022-08-10 Nanexa Ab Kietųjų nanodalelių su neorganine danga gamybos būdas ir jų naudojimas
CN104587472B (zh) * 2014-12-31 2017-12-15 广东国方医药科技有限公司 一种含纳米SiO2的包衣剂及其制备方法
NL2014348B1 (en) * 2015-02-25 2016-10-13 Univ Delft Tech Controlled release from particles encapsulated by molecular layer deposition.
BR112018017173A2 (pt) 2016-02-23 2019-01-02 Univ Colorado Regents composições e métodos para a produção e uso de formulações imunogênicas termoestáveis com compatibilidade aumentada de uso como vacinas contra um ou mais patógenos
DE102016107760B4 (de) 2016-04-26 2018-09-20 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Essbare Funktionsschichten und Überzüge auf Hybridpolymerbasis für Pharmazie und Lebensmittel
CN107543798B (zh) * 2016-06-24 2021-02-23 华仁药业股份有限公司 一种载药脂肪乳剂中甲氧基苯胺值的测定方法
CN108938592A (zh) * 2017-05-26 2018-12-07 武汉艾特米克超能新材料科技有限公司 一种低成本的药物包衣方法
CN107281152A (zh) * 2017-06-19 2017-10-24 武汉艾特米克超能新材料科技有限公司 一种基于ald包覆的药物渗透泵制剂及其制备方法
EP3740197A4 (en) * 2018-01-16 2021-11-10 Applied Materials, Inc. METAL OXIDE ENCAPSULATED DRUG COMPOSITIONS AND METHODS FOR PREPARATION
JP7432209B2 (ja) 2018-10-19 2024-02-16 東和薬品株式会社 被覆された固形製剤
EP3958846A4 (en) * 2019-04-26 2023-01-18 Applied Materials, Inc. Coated drug compositions and processes for the production thereof
GB2585077A (en) 2019-06-28 2020-12-30 Nanexa Ab Apparatus
EP4021421A4 (en) * 2019-08-27 2023-05-10 Applied Materials, Inc. VAPOR PHASE COATINGS FOR PHARMACEUTICAL SOLUTION CONTROL
CN114555031A (zh) * 2019-08-27 2022-05-27 应用材料公司 用于药物防滥用制剂的气相包衣技术
WO2021172395A1 (ja) 2020-02-26 2021-09-02 東和薬品株式会社 被覆原薬粒子
TW202211911A (zh) * 2020-06-05 2022-04-01 美商應用材料股份有限公司 經塗佈的藥物組成物及製備彼之方法
TW202216124A (zh) * 2020-10-02 2022-05-01 美商應用材料股份有限公司 製備氧化矽塗佈藥品的低溫處理
CN114532448A (zh) * 2022-03-11 2022-05-27 重庆威迪特药业有限责任公司 一种高过胃率粉末包被氧化锌制剂及其制备方法和应用
CN114732793B (zh) * 2022-04-21 2023-06-09 湖北人福药用辅料股份有限公司 一种空心胶囊及其制备方法
WO2023215312A1 (en) * 2022-05-03 2023-11-09 Applied Materials, Inc. Drug compositions and methods of preparing the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990008431A (ko) 1995-05-09 1999-01-25 피터 존스 팔슨즈 정전 코팅
CN1168789A (zh) * 1996-06-13 1997-12-31 天津达仁堂制药厂 药丸金箔包衣工艺
US6613383B1 (en) * 1999-06-21 2003-09-02 Regents Of The University Of Colorado Atomic layer controlled deposition on particle surfaces
US7972616B2 (en) * 2003-04-17 2011-07-05 Nanosys, Inc. Medical device applications of nanostructured surfaces
WO2007014464A1 (en) 2005-08-03 2007-02-08 The University Of Western Ontario Direct coating solid dosage forms using powdered materials
US9492805B2 (en) * 2005-11-01 2016-11-15 Massachusetts Institute Of Technology Initiated chemical vapor deposition of vinyl polymers for the encapsulation of particles
US8048448B2 (en) * 2006-06-15 2011-11-01 Abbott Cardiovascular Systems Inc. Nanoshells for drug delivery
US9149564B2 (en) * 2006-06-23 2015-10-06 The Regents Of The University Of California Articles comprising large-surface-area bio-compatible materials and methods for making and using them
KR100796985B1 (ko) * 2006-06-30 2008-01-22 연세대학교 산학협력단 금박막이 부분 증착된 다기능성 나노입자

Also Published As

Publication number Publication date
CN103402503A (zh) 2013-11-20
JP2014510066A (ja) 2014-04-24
WO2012116814A1 (en) 2012-09-07
KR20140011358A (ko) 2014-01-28
US20130337056A1 (en) 2013-12-19
EP2680824A1 (en) 2014-01-08
CL2013002504A1 (es) 2014-02-14
ZA201307372B (en) 2014-11-26
CA2828754A1 (en) 2012-09-07
EA201300982A1 (ru) 2014-02-28
MX2013010002A (es) 2013-12-06
AU2012222650A1 (en) 2013-10-17

Similar Documents

Publication Publication Date Title
BR112013022209A2 (pt) preparação farmacêutica sólida revestida
AR086237A1 (es) FORMULACION PARA ANTICUERPO ANTI-a4b7
BR112013025519A2 (pt) composição farmacêutica
MX356337B (es) Anticuerpos contra csf-1r humano y sus usos.
BR112014009031A2 (pt) formulações de etanercept estabilizadas com íons de metais
WO2011106072A3 (en) Use of ruthenium tetroxide as a precursor and reactant for thin film depositions
BR112013002484A2 (pt) composto, composição farmacêutica, métodos para tratar esclerose múltipla e artrite reumatoide, e, uso de um composto.
DOP2015000026A (es) Formulas de testosterona proliposomal
MX336682B (es) Anticuerpos contra csf-1r humanos y usos de los mismos.
BR112015000203A2 (pt) formulações de etanercept que exibem redução marcada em partículas sub-visíveis
CL2012002318A1 (es) Compuestos derivados de tieno [2,3-d]pirimidina, inhibidores de quinasa mnk1 y mnk2; composición farmaceutica; que los comprende; y su uso en el tratamiento de enfermedades metabolicas, hematopoyeticas, neurodegenerativas, renales, inflamatorias y cancer.
BR112015005404A2 (pt) Formas polimórficas de enzalutamida e sua preparação
EP2527429A3 (en) DAC HYP compositions and methods
UA111357C2 (uk) Аналоги епоксіейкозатриєнової кислоти, композиція на їх основі, застосування для лікування захворювань та спосіб зниження гіпертонії та нефротоксичності (варіанти)
AR088766A1 (es) Composicion farmaceutica que comprende rasagilina
BR112013033402A2 (pt) produtos de madeira revestida e método para produzir produtos de madeira revestida
UY32052A (es) 5-aminopirazoles sustituidos y uso de los mismos
AR087787A1 (es) Compuesto de benzotiazolona
BR112015001859A2 (pt) tratamento de inflamação utilizando serelaxina
AR085543A1 (es) Agomelatina, una forma cristalina vii, sus metodos de preparacion, aplicaciones y composiciones farmaceuticas
BR112013028789A2 (pt) processo
MY165513A (en) Compositions comprising extracts obtained from oil palm based materials for providing anti-inflammatory effects and method of producing thereof
MY153033A (en) Lanthanum cerium oxide thin film and its preparation thereof
BR112014013723A2 (pt) formas cristalinas da [(s)-1-carbamoil-2-(fenil-pirimidin-2-il-amino)-etil]-amida do ácido 2-(2-metil-amino-pirimidin-4-il)-1h-indol-5-carboxílico
BR112013025610A2 (pt) uso de um metapneumovírus aviário vivo, e, composição farmacêutica

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]